BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/11/2024

FDA Publishes Draft Guidance on Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics

The FDA is releasing a draft guidance to help industry prepare for the nonclinical safety evaluation of oligonucleotide-based therapeutics, which will inform clinical development and marketing of these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →